These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31487266)

  • 1. Loss of smooth muscle CYB5R3 amplifies angiotensin II-induced hypertension by increasing sGC heme oxidation.
    Durgin BG; Hahn SA; Schmidt HM; Miller MP; Hafeez N; Mathar I; Freitag D; Sandner P; Straub AC
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31487266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress.
    Durgin BG; Wood KC; Hahn SA; McMahon B; Baust JJ; Straub AC
    J Mol Cell Cardiol; 2022 Jan; 162():72-80. PubMed ID: 34536439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.
    Rahaman MM; Nguyen AT; Miller MP; Hahn SA; Sparacino-Watkins C; Jobbagy S; Carew NT; Cantu-Medellin N; Wood KC; Baty CJ; Schopfer FJ; Kelley EE; Gladwin MT; Martin E; Straub AC
    Circ Res; 2017 Jul; 121(2):137-148. PubMed ID: 28584062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smooth muscle cytochrome b5 reductase 3 deficiency accelerates pulmonary hypertension development in sickle cell mice.
    Wood KC; Durgin BG; Schmidt HM; Hahn SA; Baust JJ; Bachman T; Vitturi DA; Ghosh S; Ofori-Acquah SF; Mora AL; Gladwin MT; Straub AC
    Blood Adv; 2019 Dec; 3(23):4104-4116. PubMed ID: 31821458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide.
    Zhou Z; Martin E; Sharina I; Esposito I; Szabo C; Bucci M; Cirino G; Papapetropoulos A
    Pharmacol Res; 2016 Sep; 111():556-562. PubMed ID: 27378567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of mitochondrial superoxide decreasing ferrochelatase and heme in coronary artery soluble guanylate cyclase depletion by angiotensin II.
    Patel D; Alhawaj R; Kelly MR; Accarino JJ; Lakhkar A; Gupte SA; Sun D; Wolin MS
    Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1439-47. PubMed ID: 27037373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
    Crassous PA; Couloubaly S; Huang C; Zhou Z; Baskaran P; Kim DD; Papapetropoulos A; Fioramonti X; Durán WN; Beuve A
    Am J Physiol Heart Circ Physiol; 2012 Sep; 303(5):H597-604. PubMed ID: 22730391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heme oxygenase-1 deficiency leads to alteration of soluble guanylate cyclase redox regulation.
    Jones AW; Durante W; Korthuis RJ
    J Pharmacol Exp Ther; 2010 Oct; 335(1):85-91. PubMed ID: 20605906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.
    Agbor LN; Nair AR; Wu J; Lu KT; Davis DR; Keen HL; Quelle FW; McCormick JA; Singer JD; Sigmund CD
    JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
    Boerrigter G; Burnett JC
    Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
    Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
    J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
    Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
    Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble guanylate cyclase is required for systemic vasodilation but not positive inotropy induced by nitroxyl in the mouse.
    Zhu G; Groneberg D; Sikka G; Hori D; Ranek MJ; Nakamura T; Takimoto E; Paolocci N; Berkowitz DE; Friebe A; Kass DA
    Hypertension; 2015 Feb; 65(2):385-92. PubMed ID: 25452469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NO-induced vasodilation correlates directly with BP in smooth muscle-Na/Ca exchanger-1-engineered mice: elevated BP does not attenuate endothelial function.
    Wang Y; Zhang J; Wier WG; Chen L; Blaustein MP
    Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H221-H237. PubMed ID: 33124883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial SIRT1 prevents age-induced impairment of vasodilator responses by enhancing the expression and activity of soluble guanylyl cyclase in smooth muscle cells.
    Guo Y; Xu C; Man AWC; Bai B; Luo C; Huang Y; Xu A; Vanhoutte PM; Wang Y
    Cardiovasc Res; 2019 Mar; 115(3):678-690. PubMed ID: 30165439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.
    Potoka KP; Wood KC; Baust JJ; Bueno M; Hahn SA; Vanderpool RR; Bachman T; Mallampalli GM; Osei-Hwedieh DO; Schrott V; Sun B; Bullock GC; Becker-Pelster EM; Wittwer M; Stampfuss J; Mathar I; Stasch JP; Truebel H; Sandner P; Mora AL; Straub AC; Gladwin MT
    Am J Respir Cell Mol Biol; 2018 May; 58(5):636-647. PubMed ID: 29268036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice.
    Thoonen R; Cauwels A; Decaluwe K; Geschka S; Tainsh RE; Delanghe J; Hochepied T; De Cauwer L; Rogge E; Voet S; Sips P; Karas RH; Bloch KD; Vuylsteke M; Stasch JP; Van de Voorde J; Buys ES; Brouckaert P
    Nat Commun; 2015 Oct; 6():8482. PubMed ID: 26442659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-independent vasodilator rescues heme-oxidized soluble guanylate cyclase from proteasomal degradation.
    Meurer S; Pioch S; Pabst T; Opitz N; Schmidt PM; Beckhaus T; Wagner K; Matt S; Gegenbauer K; Geschka S; Karas M; Stasch JP; Schmidt HH; Müller-Esterl W
    Circ Res; 2009 Jul; 105(1):33-41. PubMed ID: 19478201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing the soluble guanylate cyclase heme redox state in blood vessels.
    Tawa M; Okamura T
    Vascul Pharmacol; 2022 Aug; 145():107023. PubMed ID: 35718342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled agonists of soluble guanylate cyclase induce selective pulmonary vasodilation.
    Evgenov OV; Kohane DS; Bloch KD; Stasch JP; Volpato GP; Bellas E; Evgenov NV; Buys ES; Gnoth MJ; Graveline AR; Liu R; Hess DR; Langer R; Zapol WM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1138-45. PubMed ID: 17872487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.